Author

Brent Dickinson

Miragen Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

Farida AhangariiD· 1 shared Gauri SainiiD· 1 shared Gisli R. JenkinsiD· 1 shared Guying Yu· 1 shared Jose D. Herazo‐MayaiD· 1 shared Joseph DeIullis· 1 shared Kevin M. Rigby· 1 shared Linda A. Pestano· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Farida AhangariORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A lung targeted miR-29 Mimic as a Therapy for Pulmonary Fibrosis

Maurizio Chioccioli, Subhadeep Roy, Rachel Newell, Linda A. Pestano, Brent Dickinson, Kevin M. Rigby, Jose D. Herazo‐Maya, Gisli R. Jenkins, Steward Ian, Gauri Saini, Simon R. Johnson, Rebecca Braybrooke, Guying Yu, Maor Sauler, Farida Ahangari, , Naftali Kaminski

A stabilized miR-29 mimic, MRG-229, shows efficacy at lower doses and good safety in preclinical models, supporting its development for pulmonary fibrosis.

EBioMedicine · Oct 17, 2022Peer-reviewedMolecular Biology